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 
Abstract—A physiological control system was developed for 
a rotary left ventricular assist device (LVAD) in which the 
target pump flow rate (LVADQ) was set as a function of left 
atrial pressure (LAP), mimicking the Frank-Starling 
mechanism.  The control strategy was implemented using 
linear PID control and was evaluated in a pulsatile mock 
circulation loop using a prototyped centrifugal pump by 
varying pulmonary vascular resistance to alter venous return.  
The control strategy automatically varied pump speed (2460 to 
1740 to 2700 RPM) in response to a decrease and subsequent 
increase in venous return.  In contrast, a fixed-speed pump 
caused a simulated ventricular suction event during low venous 
return and higher ventricular volumes during high venous 
return. The preload sensitivity was increased from 0.011 
L/min/mmHg in fixed speed mode to 0.47L/min/mmHg, a value 
similar to that of the native healthy heart. The sensitivity 
varied automatically to maintain the LAP and LVADQ within 
a predefined zone. This control strategy requires the 
implantation of a pressure sensor in the left atrium and a flow 
sensor around the outflow cannula of the LVAD.  However, 
appropriate pressure sensor technology is not yet commercially 
available and so an alternative measure of preload such as 
pulsatility of pump signals should be investigated. 
I. INTRODUCTION 
otary left ventricular assist devices (LVADs) can 
successfully support a failing left ventricle (LV) whilst 
the patient awaits recovery or transplant, or be used as 
destination therapy for those deemed unsuitable for 
transplantation [1].  However, one limiting factor of rotary 
LVADs is that their preload sensitivity is significantly 
smaller than that of the native heart, which lies between 
0.213 and 0.9 L/min/mmHg [2, 3]. 
This preload insensitivity means that, when operated at a 
constant speed, the pump output cannot passively change 
sufficiently in response to the frequent variations in preload 
induced by changes in posture, exercise, straining or in 
response to intercurrent illness. [4-6].  Speed changes are 
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required to avoid hazardous events including ventricular 
suction, which results in reduced forward flow of blood, 
hence inducing ischaemia on the heart as well as distal 
organs, haemolysis, release of ventricular thrombus leading 
to stroke, tissue damage at VAD inlet and even subsequent 
right ventricular dysfunction [7-9].  The addition of an active 
physiological control system is required to automatically 
match LVAD flow with venous return, thus ensuring 
appropriate cardiac output at all times whilst avoiding 
ventricular suction. 
A number of physiological control systems for rotary 
LVADs have already been developed that detect imminent 
suction by monitoring pump signals (such as current, 
differential pressure, and power) and operate the pump at the 
highest speed possible without suction occurring [10, 11].  
However, this strategy does not prevent suction during 
sudden drops in venous return, which may occur as the 
patient stands up or during straining.  It can also be argued 
that it is unphysiological to maintain a constant ventricular 
volume, especially the low volume maintained in these 
suction-avoidance control strategies, as it may disrupt right 
ventricular function. 
The Frank-Starling law is responsible for relating cardiac 
output to preload, ensuring the outflow from the ventricles 
matches the venous return.  This mechanism is diminished in 
heart failure due to weaker ventricles.  In this work, we 
propose a control strategy for a rotary LVAD, in which the 
LVAD flow (LVADQ) is functionally dependent on preload, 
represented by left atrial pressure (LAP), in order to directly 
mimic the Frank-Starling mechanism.  This strategy 
measures LAP directly using a pressure sensor, and sets a 
target LVADQ using characteristic Frank-Starling curves 
described by Guyton [12].  A linear proportional, integral 
and derivative (PID) controller is then used to vary the pump 
speed to control the mean LVADQ, measured using a flow 
sensor.  This strategy was evaluated in a pulsatile mock 
circulation loop (MCL) using a prototyped rotary pump.  Its 
response to changes in venous return, caused by variations in 
pulmonary vascular resistance, was compared to that of a 
LVAD operated at a constant speed.  
II. MATERIALS AND METHODS 
A. Mock Circulation Loop and Rotary Pump 
A MCL is a mechanical representation of the human heart 
and circulatory system.  The MCL used in this study is a 5-
element Windkessel biventricular model of the circulatory 
system, which uses a regulated supply of compressed air to 
pump fluid through a simulated cardiovascular circuit [13].  
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Fig. 1.  Block diagram of the LVAD physiological control strategy. ω = 
pump rotational speed.  
 
This circuit simulates cardiovascular resistance, inertance 
and compliance in both pulmonary and systemic circulation.  
Left and right atrial and ventricular pressures, aortic 
pressure, pulmonary arterial pressure and LVAD inlet/outlet 
pressures were monitored using silicone based transducers 
(PX181B-015C5V, OMEGA Engineering, Connecticut, 
USA).  Systemic, pulmonary and LVAD flow rates were 
monitored using an ultrasonic flow meter (TS410-10PXL, 
Transonic Systems, NY, USA). All data were recorded using 
a dSPACE 1103 controller board (Ceanet Pty Ltd, Sydney, 
Australia).  A solution of 40wt% glycerol was used as a 
surrogate for human blood.  The loop was modified so that 
its ventricles exhibited a native Frank-Starling mechanism. 
A prototyped mixed-flow rotary pump with an impeller 
diameter of 50mm was used to simulate a rotary LVAD.  
The impeller was driven by a DC motor (AMax 236669, 
Maxon Motors, Sachseln, Switzerland).  The rotational 
speed of the DC motor was measured using a digital encoder 
(143306 HEDL, Maxon Motors, Sachseln, Switzerland).   
B. Control Strategy 
The effect of the Frank-Starling mechanism is that cardiac 
output (CO) is dependent on preload.  Specifically, the CO 
increases with increasing LAP until it saturates at a 
maximum [12].  Our control algorithm aims to make the 
blood flow rate through the pump dependent on preload, 
replicating the preload sensitivity of the native heart.  A 
block diagram of the complete control system is shown in 
Figure 1.  The LAP is measured directly using a pressure 
sensor, and a target LVADQ is set based upon a functional 
relationship between these two variables.  A PID controller 
was used to adjust pump speed to minimise the error 
between the target and measured LVADQ. The PID 
controller gains were set manually using the Zeigler-
Nicholls tuning method. Both the measured LAP and the 
measured LVADQ were passed through low pass filters with 
a cut-off frequency of 0.5Hz to obtain their mean values.  
The functional relationship between LVAD flow 
(LVADQ) and LAP is interpolated from the Frank-Starling 
characteristic curves described by Guyton [12].  These 
curves were normalised and a function was fitted using LAB 
FIT software (Universidade Federal de Campina Grande, 
Campina Grande, Paraíba, Brazil) giving the function:  
      
          
                   
                (1)  
The sensitivity of these curves is hereby defined as the 
approximate slope of the linear portion of Equation 1. This 
relationship was scaled along the pressure axis to produce 
curves of different sensitivities, which reflects the different 
inotropic states of the heart (Figure 2).  When used with a 
constant sensitivity (denoted as “Controller On, 
Autosensitivity Off” in the results), the control strategy 
should be able to ensure no suction or overfilling during 
preload changes caused by straining and changes in posture.  
However, no single sensitivity is appropriate for all 
scenarios.  Changes in a patient’s cardiac demand or heart 
condition may require a different sensitivity in order to avoid 
suction or overfilling.  The control strategy must therefore 
be able to vary the sensitivity automatically (denoted as 
“Controller On, Autosensitivity On” in the results).  Our 
control strategy maintains the sensitivity constant until the 
current values of LVADQ and LAP (herein referred to as the 
operating point (OP)) move outside a predefined ideal 
operating zone (IOZ).  A proportional plus integral (PI) 
controller, tuned manually using the Zeigler-Nichols tuning 
method, is then used to adjust the sensitivity until the OP 
returns to the IOZ.  The IOZ is defined by a minimum and 
maximum LAP and LVADQ.  The IOZ should be set by a 
clinician at the time of implantation, based on what they 
believe are safe boundaries for each particular patient.  For 
this study the IOZ was defined by a minimum and maximum 
LAP of 4 and 8 mmHg, and a minimum and maximum 
LVADQ of 2 and 5 L/min respectively, in order to avoid 
suction events and to demonstrate the autosensitivity control.  
C. Simulation Protocol 
A MCL was used to evaluate the control strategy.  Five 
scenarios were simulated in the MCL: a normal heart, LV 
failure without an LVAD, LV failure supported by an 
LVAD operated at fixed speed, and LV failure supported by 
a LVAD operated using the Frank-Starling control strategy, 
both with and without the autosensitivity control.  It was 
assumed right heart function remained normal during the LV 
failure scenarios. 
 Fig. 2.  Functional relationship between LVAD flow rate (LVADQ) and 
left atrial pressure (LAP), which was used to set a target flow rate for a 
specific LAP.   
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Fig. 3.  Mean LVADQ vs Mean LAP over time, showing the preload 
sensitivity of each of three LVAD control strategies tested in the MCL.  C 
On, A Off = controller on, autosensitivity control off.  C On, A On = 
controller on, autosensitivity control on.  PVR = pulmonary vascular 
resistance  
The simulation protocol was as follows: First, the MCL was 
primed with a mean vascular pressure of 8.5mmHg.  The 
ventricles of the loop were then started and the appropriate 
heart condition was set by adjusting the ventricular 
contractilities and vascular resistances accordingly.  The 
initial haemodynamics for the normal and the failing LV 
conditions are shown in Table I.  The LVAD and the 
physiological controller were then switched on.  For the 
Frank-Starling control system, an initial sensitivity of 0.47 
L/min/mmHg was chosen to obtain a normal mean aortic 
pressure (MAP) of approximately 100mmHg. For the fixed 
speed control, the speed was set at 2460 revolutions per 
minute (RPM) to obtain the same initial haemodynamics. 
After 30 seconds, the system was then disturbed by a step 
increase in pulmonary vascular resistance (PVR) from 20 
MPa.s/m3 (Stage 1) to 60 MPa.s/m3 (Stage 2), reducing 
venous return to the left atrium.  At 90 seconds, the 
resistance was then decreased from 60 to 7 MPa.s/m
3
 (Stage 
3), increasing venous return to the left atrium.   The changes 
in MAP, LAP and cardiac output (CO) were observed and 
compared in all five scenarios.  
III. EXPERIMENTAL RESULTS 
The results of the study are detailed in Table I.  The 
variations in PVR firstly reduced, and then increased, the 
venous return to the left atrium. The Frank-Starling control 
system responded in a similar manner to the simulated 
normal LV by automatically varying the pump speed in 
order to obtain similar changes in MAP (92.7 to 50.9 to 
113.5 mmHg) and flow rate (4.2 to 2.8 to 4.7 L/min).  In 
contrast, there was very little change in flow rate and aortic 
pressure in the fixed speed pump.  This constant pump flow, 
combined with reduced venous return during Stage 2, 
resulted in the approach of ventricular suction (LAP = 0) 
during this stage.   
 
Figure 3 shows the sensitivity of the LVAD flow rate to 
changes in LAP for all three methods of LVAD control.  As 
expected, the sensitivity of the LVAD operated at constant 
speed was significantly smaller than that of the controlled 
LVAD, which resulted in ventricular suction during low 
venous return.  In contrast, no suction or overfilling was 
observed with the Frank-Starling controller. The addition of 
the autosensitivity control varied the sensitivity from 0.47 to 
0.35 to 0.41 L/min/mmHg in order to maintain the operating 
point within the IOZ.  The use of this IOZ ensured that the 
operating point remained away from the point of imminent 
suction, whilst avoiding ventricular overfilling. 
Figure 3 also shows that the control system did not track 
the target LVADQ perfectly, due to the use of a low-pass 
filter on the LVADQ.  
IV. DISCUSSION 
The Frank-Starling LVAD control mechanism 
successfully varied pump speed in response to changes in 
preload, safely avoiding suction and overfilling.  This 
implies that this mechanism can cope with the daily 
variations in venous return caused by postural changes and 
straining.  The addition of the autosensitivity mechanism 
successfully varied the sensitivity in order to maintain the 
pump operation within a predefined IOZ. 
In this study the IOZ was set arbitrarily in order to show 
the effect of the autosensitivity control and to safely operate 
the pump away from suction.  In reality, the choice of IOZ 
will depend on type of LVAD therapy as determined by the 
clinician.  A tall, thin IOZ would maintain the LAP within a 
small range and may be useful during initial operation and 
stabilisation of the device.  Gradual widening of the IOZ 
would allow the ventricles to undergo changes in volume 
with changes in preload, which may be useful in ventricular 
recovery.   
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Fixed Speed (2400 RPM)
C On, A Off
C on, A On
Initial Sensitivity (0.47)
Second Sensitivity (0.35)
Final Sensitivity (0.41)
2. PVR = 
60 MPa.s/m3
1. PVR = 
20 MPa.s/m3
3. PVR = 
7 MPa.s/m3
TABLE I 
HAEMODYNAMIC VALUES FOR VARIOUS TESTING PROTOCOLS IN A STEADY 
STATE SITUATION (1), EXPERIENCING A REDUCTION IN LA VENOUS RETURN 
(2) AND AN INCREASE IN LA VENOUS RETURN (3). 
Stage MAP (mmHg) LAP (mmHg) CO (L/min)  ω (RPM) 
Normal LV 
1 99.0 8.6
 
4.8 - 
2 56.0 5.2 3.4 - 
3 105.0 9.2 5.1 - 
Failing LV (unsupported) 
1 48.0 10.4 3.0 - 
2 40.0 7.5 2.6 - 
3 52.7 12.16 3.3 - 
Failing LV (supported, fixed speed) 
1 94.4 6.0 4.2 2460 
2 87.8 0.0 3.9 2460 
3 97.2 8.8 4.3 2460 
Failing LV (supported, C On, A Off) 
1 92.7 6.2 4.2 2460 
2 50.9 3.5 2.8 1740 
3 113.5 7.2 4.7 2700 
Failing LV (supported, C On, A On) 
1 95.7 6.3 4.2 2460 
2 48.2 4.1 2.6 1650 
3 107.0 7.9 4.5 2580 
MAP = mean aortic pressure, LAP = left atrial pressure, CO = cardiac 
output
a, mmHg = millimeters of mercury, L/min = litres per minute, ω = 
pump speed, RPM = revolutions per minutes. 
a
Cardiac output during 
supported simulations only consisted of LVAD flow 
  
 
Moscato et al. (2010) developed a similar control strategy 
in which the target LVADQ was linearly related to end-
diastolic LV pressure (another measure of preload), to 
maintain a constant afterload impedance [14]. This 
impedance, effectively the preload sensitivity, is adjusted by 
a clinician.  In comparison, our control strategy incorporates 
an autosensitivity mechanism that ensures the operating 
point remains in a predefined region by automatically 
varying sensitivity. The only clinical input required is the 
initial selection of the IOZ, reducing the patient dependence 
on clinical staff and therefore making this control 
mechanism appropriate for patients discharged from hospital 
care. 
 The preload sensitivity of the control system (which 
varied between 0.35 and 0.47) is of the same order of 
magnitude as the native left ventricle, which has been 
reported to be between 0.213 and 0.9 L/min/mmHg [2, 3]. It 
is also significantly higher than that of a fixed-speed LVAD, 
reported as 0.105 L/min/mmHg [2]. The range of 
sensitivities used by the control system will depend on the 
clinician’s choice of IOZ. 
It can be seen in Figure 3 that the PID controller does not 
track the target LVADQ perfectly.  This may pose a problem 
when the system is operating with higher sensitivities 
because the flow rate may not decrease fast enough to avoid 
suction during low venous return. Further investigation into 
the use of non-linear adaptive control techniques is being 
undertaken by the group to minimize this tracking error. The 
use of a moving average filter instead of a low-pass filter 
may also improve the time-domain response of the control 
system. 
The main limitation of this control strategy is the reliance 
on both a pressure and a flow sensor.  Implantable flow 
sensors consist of a flow probe clamped around an outlet 
cannula, and are part of the HeartAssist series of LVADs 
[15], however the long term reliability of these sensors is 
questionable [16]. There are some left atrial pressure sensors 
currently in development [17], but none yet commercially 
available. An alternative to using a direct measurement of 
LAP would be to use the pulsatility of the flow or pump 
current signals, caused by residual ventricle contractility, as 
an indicator of preload  [10].  However, if the ventricle has 
no residual contractility, then alternative LAP estimation 
techniques will have to be developed. 
V. CONCLUSION 
In this study, a Frank-Starling-like control system for 
rotary LVADs is presented.  This system varies the target 
LVADQ in response to changes in venous return. This 
system was evaluated in a mock circulation loop by 
comparing its response to an LVAD operated at fixed speed.  
The control strategy restored preload sensitivity to 
0.47mmHg, the same order of magnitude as the native LV. 
The addition of an autosensitivity mechanism maintained the 
operating point within desired limits, improving the safety of 
this mechanism. The control strategy is limited by the 
requirement of an implanted pressure sensor in the left 
atrium. It may, however, be possible to use parameters such 
as pulsatility of pump signals as alternative control inputs.  
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